TC-Mps1-12 (25-100 mg/kg; p.o.; daily; for 19 days) inhibits the growth of A549 cells in a dose-dependent manner in vivo. At a dose of 100 mg/kg, TC-Mps1-12 exhibits 47% tumor growth inhibition without body weight loss.
TC-Mps1-12 shows good PK properties with a Cmax of 3542 ng/mL and AUC of 6604 ng h/mL at an oral dose of 25 mg/kg.
Animal Model: |
A549 mouse xenograft model |
Dosage: |
25 mg/kg, 50 mg/kg, 100 mg/kg |
Administration: |
Oral administration; once daily; for 19 days |
Result: |
Inhibited the growth of A549 cells in a dose-dependent manner. |
Animal Model: |
A549 mouse xenograft model (pharmacokinetic ) |
Dosage: |
25 mg/kg |
Administration: |
Oral administration |
Result: |
Cmax = 3542 ng/mL, AUC = 6604 ng h/mL |